Maria M. M. Santos - Search Results

Year	Number of Results
2005	1
2007	3
2009	3
2010	3
2011	3
2012	1
2013	5
2014	4
2015	4
2016	4
2017	4
2018	3
2019	5
2020	5
2021	5
2022	4
2023	3
2024	1

1

Antimalarial drugs: what's new in the patents?

Lopes EA, Santos MMM, Mori M. Lopes EA, et al. Among authors: santos mmm. Expert Opin Ther Pat. 2023 Mar;33(3):151-168. doi: 10.1080/13543776.2023.2203814. Epub 2023 Apr 20. Expert Opin Ther Pat. 2023. PMID: 37060305 Review.

2

An Update on MDMX and Dual MDM2/X Inhibitors.

Espadinha M, Barcherini V, Lopes EA, Santos MMM. Espadinha M, et al. Among authors: santos mmm. Curr Top Med Chem. 2018;18(8):647-660. doi: 10.2174/1568026618666180604080119. Curr Top Med Chem. 2018. PMID: 29866007 Review.

3

Recent Progress in the Development of Indole-Based Compounds Active against Malaria, Trypanosomiasis and Leishmaniasis.

Pacheco PAF, Santos MMM. Pacheco PAF, et al. Among authors: santos mmm. Molecules. 2022 Jan 5;27(1):319. doi: 10.3390/molecules27010319. Molecules. 2022. PMID: 35011552 Free PMC article. Review.

4

Small Molecules Targeting Mutant P53: A Promising Approach for Cancer Treatment.

Lopes EA, Gomes S, Saraiva L, Santos MMM. Lopes EA, et al. Among authors: santos mmm. Curr Med Chem. 2019;26(41):7323-7336. doi: 10.2174/0929867325666181116124308. Curr Med Chem. 2019. PMID: 30444195 Review.

5

Michael acceptors as cysteine protease inhibitors.

Santos MM, Moreira R. Santos MM, et al. Mini Rev Med Chem. 2007 Oct;7(10):1040-50. doi: 10.2174/138955707782110105. Mini Rev Med Chem. 2007. PMID: 17979807 Review.

6

Chemical Variations on the p53 Reactivation Theme.

Ribeiro CJ, Rodrigues CM, Moreira R, Santos MM. Ribeiro CJ, et al. Among authors: santos mm. Pharmaceuticals (Basel). 2016 May 13;9(2):25. doi: 10.3390/ph9020025. Pharmaceuticals (Basel). 2016. PMID: 27187415 Free PMC article. Review.

7

Indolo[2,3-a]quinolizidines and Derivatives: Bioactivity and Asymmetric Synthesis.

Perez M, Espadinha M, Santos MM. Perez M, et al. Among authors: santos mm. Curr Pharm Des. 2015;21(38):5518-46. doi: 10.2174/1381612821666151002112934. Curr Pharm Des. 2015. PMID: 26429714 Free article. Review.

8

Metabolism-Guided Optimization of Tryptophanol-Derived Isoindolinone p53 Activators.

Barcherini V, Loureiro JB, Sena A, Madeira C, Leandro P, Saraiva L, Antunes AMM, Santos MMM. Barcherini V, et al. Among authors: santos mmm. Pharmaceuticals (Basel). 2023 Jan 19;16(2):146. doi: 10.3390/ph16020146. Pharmaceuticals (Basel). 2023. PMID: 37259297 Free PMC article.

9

Discovery of spirooxadiazoline oxindoles with dual-stage antimalarial activity.

Lopes EA, Mestre R, Fontinha D, Legac J, Pei JV, Sanches-Vaz M, Mori M, Lehane AM, Rosenthal PJ, Prudêncio M, Santos MMM. Lopes EA, et al. Among authors: santos mmm. Eur J Med Chem. 2022 Jun 5;236:114324. doi: 10.1016/j.ejmech.2022.114324. Epub 2022 Mar 28. Eur J Med Chem. 2022. PMID: 35390711

10

Mutant p53 reactivator SLMP53-2 hinders ultraviolet B radiation-induced skin carcinogenesis.

Loureiro JB, Ribeiro R, Nazareth N, Ferreira T, Lopes EA, Gama A, Machuqueiro M, Alves MG, Marabini L, Oliveira PA, Santos MMM, Saraiva L. Loureiro JB, et al. Among authors: santos mmm. Pharmacol Res. 2022 Jan;175:106026. doi: 10.1016/j.phrs.2021.106026. Epub 2021 Dec 8. Pharmacol Res. 2022. PMID: 34890775

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

53 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year